Suppr超能文献

一种使用眼科粘弹剂的新型 Descemet 膜内皮移植物标记技术。

A Novel Marking Technique for Descemet Membrane Endothelial Graft Using an Ophthalmic Viscoelastic Device.

机构信息

*Department of Ophthalmology, Assaf Harofeh Medical Center, Zerifin, Israel; †Department of Ophthalmology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel; and ‡Department of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel.

出版信息

Cornea. 2021 Apr;40(4):529-532. doi: 10.1097/ICO.0000000000002614.

Abstract

PURPOSE

To describe the viscoelastic marking technique, a novel marking technique of Descemet membrane endothelial keratoplasty (DMEK) grafts that enables usage of a single donor cornea for 2 surgeries-one that uses Descemet membrane and endothelium (DMEK) and the other using the stroma and Bowman layer.

METHODS

A retrospective case analysis was performed on 26 eyes of 26 consecutive patients who underwent DMEK using the "viscoelastic marking technique." In this novel technique, an ophthalmic viscoelastic device (Healon 5) is placed over the endothelial side. Descemet membrane is then folded in half over the ophthalmic viscoelastic device with the stromal side up, and the F mark is drawn on the stromal side of the folded Descemet membrane. Primary outcome was best spectacle-corrected visual acuity, and secondary outcomes included graft detachment and rebubble rate, graft failure, and endothelial cell density.

RESULTS

Mean best spectacle-corrected visual acuity improved significantly from 1.0 ± 0.7 logarithm of the minimum angle of resolution (LogMAR) before the surgery to 0.9 ± 0.7 LogMAR, 0.5 ± 0.6 LogMAR, 0.4 ± 0.2 LogMAR, and 0.4 ± 0.4 LogMAR at 1, 3, 6, and 12 months after surgery, respectively. Seven eyes (27%) had partial graft detachment that required air injection. Primary failure occurred in 3 eyes (11%). There were no free-floating donors or recognized inverted donors. The endothelial cell density loss at 12 months after surgery was a cell-loss rate of 38.3%.

CONCLUSIONS

The viscoelastic marking technique is a simple, approachable, and safe technique for marking DMEK grafts while preserving the anterior cornea for additional surgery.

摘要

目的

描述黏弹剂标记技术,这是一种新型的 Descemet 膜内皮角膜移植术(DMEK)移植物标记技术,可使一枚供体角膜用于完成 2 次手术,一次是行 Descemet 膜和内皮(DMEK)手术,另一次是行基质和Bowman 层手术。

方法

对 26 例(26 只眼)连续接受 DMEK 手术的患者进行回顾性病例分析,这些患者均采用“黏弹剂标记技术”。在该新技术中,将眼科黏弹剂(Healon 5)置于内皮面。然后将角膜基质面朝上对折,将黏弹剂置于对折的内皮层上,在内皮层折叠的角膜上画出 F 标记。主要观察指标是最佳矫正视力,次要观察指标包括移植物脱离和再气泡率、移植物失败和内皮细胞密度。

结果

平均最佳矫正视力从术前的 1.0±0.7 最小角分辨力对数(LogMAR)显著提高到术后 1、3、6 和 12 个月的 0.9±0.7 LogMAR、0.5±0.6 LogMAR、0.4±0.2 LogMAR 和 0.4±0.4 LogMAR。7 只眼(27%)发生部分移植物脱离,需要注入空气。3 只眼(11%)发生原发性失败。没有游离供体或识别到倒置供体。术后 12 个月内皮细胞密度丢失率为 38.3%。

结论

黏弹剂标记技术是一种简单、可行、安全的 DMEK 移植物标记技术,同时可保留前角膜用于额外手术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验